BRIGHT MINDS BIOSCIENCES INC. — Form SCHEDULE 13D/A
Filed July 2, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
A Schedule 13D/A (amended beneficial ownership statement) was filed on July 2, 2026, by McDonald Ian regarding Bright Minds Biosciences Inc. (CIK 0001827401), a pharmaceutical preparations company. The filing stub does not disclose the actual shareholding percentages, share counts, dollar amounts, or the nature of the amendment—only that an amendment to a prior Schedule 13D was submitted.
Why this rating
No material terms disclosed; likely routine amendment. Company scale unknown but pharma micro-cap implied. Cannot assess without actual holdings data.
View original filing on SEC.gov ↗
See more from July 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.